Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
North America (Primary) | PRIMARYNOAM | Univ | 8,145 | 59,660,955 | 0.15% | 1.60% | 6.01% | 6.51% | 16.95% | 26.43% |
Healthcare | HEALTHCARE | Sector | 1,333 | 6,612,544 | 0.02% | 1.84% | 6.01% | 1.11% | 14.01% | 14.79% |
Biopharmaceuticals | BIOPHARMA | SubSec | 675 | 3,052,063 | -0.14% | 2.02% | 4.26% | -1.18% | 23.58% | 30.63% |
System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 308 | 1,574,549 | 0.13% | 2.15% | 4.25% | 0.24% | 22.96% | 18.88% |
Ophthalmology Biopharmaceuticals | OPHTHALMOLOGY | SubInd | 17 | 121,306 | 1.01% | 0.53% | 7.68% | -0.81% | 19.00% | 26.50% |
Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
Apellis Pharmaceuticals, Inc. | APLS:USAAPLS:USA | Stock | 1 | 5,010 | -1.64% | -1.62% | -13.05% | -39.12% | -13.74% | -52.79% |
Bausch + Lomb Corp. | BLCO:USABLCO:USA | Stock | 1 | 5,148 | -3.87% | -4.93% | 2.30% | 0.41% | -6.57% | -24.52% |
EyePoint Pharmaceuticals, Inc. | EYPT:USAEYPT:USA | Stock | 1 | 591 | -5.43% | -2.07% | -32.34% | -57.26% | 91.59% | 93.15% |
Ophthalmology Biopharmaceuticals | OPHTHALMOLOGY | SubInd | 17 | 121,306 | 1.01% | 0.53% | 7.68% | -0.81% | 19.00% | 26.50% |
Regeneron Pharmaceuticals, Inc. | REGN:USAREGN:USA | Stock | 1 | 108,248 | 1.48% | 0.87% | 9.88% | 3.74% | 23.32% | 31.41% |
S&P 500 | SPY:USASPY:USA | Benchmark | 14,703 | 77,878,209 | 0.14% | 1.65% | 5.99% | 6.91% | 18.44% | 28.12% |
* Colors indicate performance relative to the benchmark.